Searchable abstracts of presentations at key conferences in endocrinology

ea0029p99 | Adrenal cortex | ICEECE2012

Cushing’s disease – limitations and boundaries

Idriceanu J. , Preda C. , Galesanu C. , Ungureanu M. , Scripcariu V. , Vasiliu I. , Potorac I. , Popovici R. , Mogos V. , Vulpoi C.

Introduction: Cushing’s disease is the most frequent cause of hypercortisolism. Although the classical form is easy to diagnose, nonspecific features raise differential diagnosis problems. Severe forms are associated with high mortality, but subclinical hypercortisolism also has significant morbidity.Patients and methods: Retrospective study of Cushing’s disease evolution in 14 patients, diagnosed between 2000 and 2011 (11 women, 3 men, age at ...

ea0029p419 | Clinical case reports - Thyroid/Others | ICEECE2012

Subacute or hashimoto thyroiditis? a diagnostic dilemma: case report

Popovici R. , Ciobanu D. , Ionescu L. , Idriceanu J. , Vasiliu I. , Potorac I. , Bivoleanu E. , Cristea C. , Mogos V. , Vulpoi C.

Introduction: Subacute thyroiditis (SAT) is characterized by cervical pain. Rarely, other thyroid diseases, like Hashimoto’s thyroiditis (HT), may be associated with cervical pain, leading to confusions with SAT. We report a particular case of painful goitre.Case report: D Maria, 50 years old, presented with cervical pain, low grade fever, inflammatory syndrome (ESR=132 mm/1 h), and was diagnosed with SAT. Thyroid function was normal. Ultrasound (US...

ea0064006 | Endocrine consequences of immune checkpoint inhibitors | BES2019

Endocrine consequences of immune checkpoint inhibitors

Chachati A-S , Potorac I , Petrossians P , Beckers A

Immune checkpoints inhibitors have fundamentally changed the management of oncologic patients. These treatments consist of monoclonal antibodies directed against CTLA-4 (cytotoxic T-lymphocyte antigen 4), PD-1 (programmed cell death protein-1) and PD-L1 (one of its ligands). By blocking these receptors or ligands, the antibodies reverse the immune tolerance induced by the cancerous cell on the T-lymphocyte and favour lymphocytic reactivation and anti-tumor activity. Immune tol...

ea0026p639 | Clinical case reports | ECE2011

GH in Prader–Willi syndrome: to treat or not to treat

Vulpoi C , Rusu C , Boisteanu D , Vasiliu I , Idriceanu J , Balcan R , Potorac I , Mogos V

Introduction: Prader–Willi (PWS) is a complex genetic syndrome characterized by dysmorphic features, hypotonia, mental retardation, behavioral abnormalities, hyperphagia with progressive obesity, and endocrine dysfunctions as hypogonadism and GH deficiency. GH treatment is recommended, the major concern being aggravation of sleep apnea.Cases report: We present 2 cases with specific clinical features and genetically confirmed PWS (del 15 q11.2–q...

ea0029p389 | Clinical case reports - Pituitary/Adrenal | ICEECE2012

Hyponatremia and cytolysis as first signs of decompensated pituitary insufficiency: case report

Potorac I. , Preda C. , Cimpoesu D. , Stanciu R. , Idriceanu J. , Vasiliu I. , Leustean L. , Ungureanu M. , Mogos V. , Vulpoi C.

Introduction: Pituitary insufficiency of the adult is a rare pathology (~30–40/1 000 000 per year). Among the acquired causes, Sheehan syndrome (SS) is often characterized by an insidious evolution, which allows it to pass unnoticed for a long time.Case report: R Maria, 58 years-old, known with SS for 10 years, was hospitalized in the ER with severe asthenia, obnubilation, symptomatic arterial hypotension. Laboratory studies revealed severe hyponatr...

ea0029p1316 | Paediatric endocrinology | ICEECE2012

Lipid storage myopathy in a child with idiopathic short stature

Bivoleanu E. , Constantinescu A. , Alexianu M. , Rusu C. , Vasiliu I. , Idriceanu J. , Potorac I. , Popovici R. , Vulpoi C.

Introduction: Lipid storage myopathy (LSM) is characterized by increased lipid droplets in muscle fibers. Primary carnitine deficiency is the most frequent cause of LSM, clinical presentation ranging from asymptomatic to progressive muscle weakness or cardiomyopathy, carnitine supplementation being effective with remission of symptoms.Case report: In february 2007 R.A. born in 1996 presented progressive muscle weakness with elevated muscular enzymes (LDH...